Morgan Stanley (NYSE:MS) has a beta of 1.55, a 12-month trailing P/E ratio of 12.09, and a growth ratio of 2.58. The stock’s Relative Strength Index (RSI) is 70.06, with weekly volatility at 2.17% and ATR at 2.06. The MS stock’s 52-week price range has touched low of $43.52 and a $91.35 high. Its shares traded higher over the last trading session, gaining 1.28% on 06/01/21. The shares fell to a low of $91.87 before closing at $92.11. Intraday shares traded counted 9.1 million, which was 15.13% higher than its 30-day average trading volume of 10.72M. MS’s previous close was $90.95 while the outstanding shares total 1.79B.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Investors have identified the Capital Markets company Morgan Stanley as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $170.15 billion, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
Morgan Stanley (MS) Fundamentals that are to be considered.
MS were able to record 26.35 billion as free cash flow during the 07/15/2021 quarter of the year, this saw their quarterly net cash flow reduce by 12.46 billion. In cash movements, the company had a total of 26.88 billion as operating cash flow.
Potential earnings growth for Morgan Stanley (MS)
In order to determine the future investment potential for this stock, we will have to analyze key trends that affect it. During the 07/15/2021 quarter of the year, Morgan Stanley recorded a total of 15.72 billion in revenue. This figure implies that they witnessed a quarterly year/year change in their earnings with 37.79% coming in sequential stages and their sales for the 07/15/2021 quarter increasing by 15.08%.
What matters though is how it ends. When the core data for the company is broken down, then the stock sounds interesting. The company spent 10.38 billion trying to sell their products during the last quarter, with the result yielding a gross income of 5.34 billion. This allows shareholders to hold on to 1.79B with the recently reported earning now reading 2.22 cents per share. This is a figure that compared to analyst’s prediction for their 07/15/2021 (2.22 cents a share).
Having a look at the company’s valuation, the company is expected to record 6.75 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on MS sounds very interesting.
Is the stock of MS attractive?
In related news, Head of Investment Management, SIMKOWITZ DANIEL A sold 73,162 shares of the company’s stock in a transaction that recorded on Apr 19. The sale was performed at an average price of 80.06, for a total value of 5,856,984. As the sale deal closes, the Chief Risk Officer, Hotsuki Keishi now sold 22,746 shares of the company’s stock, valued at 1,734,382. Also, Head of Tech/Ops/Resilience, ROONEY ROBERT P sold 15,169 shares of the company’s stock in a deal that was recorded on Feb 09. The shares were price at an average price of 74.36 per share, with a total market value of 1,128,012. Following this completion of acquisition, the Head of Wealth Management, SAPERSTEIN ANDREW M now holds 19,832 shares of the company’s stock, valued at 1,438,812. In the last 6 months, insiders have changed their ownership in shares of company stock by 0.20%.
18 out of 26 analysts covering the stock have rated it a Buy, while 5 have maintained a Hold recommendation on Morgan Stanley. 0 analysts has assigned a Sell rating on the MS stock. The 12-month mean consensus price target for the company’s shares has been set at $91.58.
